货号:A464324
同义名:
B-榄香烯
/ Levo-β-elemene; (-)-β-Elemene
β-Elemene是一种天然倍半萜,存在于多种植物中,赋予某些植物花香气味。研究表明该化合物能够抑制多种肿瘤的增殖。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | ERK ↓ ↑ | ERK1 ↓ ↑ | ERK2 ↓ ↑ | ERK5 ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEL-22379 |
+
ERK, IC50: 0.5 μM |
+
ERK, IC50: 0.5 μM |
98% | ||||||||||||||||
| Pluripotin |
++
ERK1, Kd: 98 nM |
RasGAP | 98+% | ||||||||||||||||
| FR 180204 |
+
ERK1, Ki: 0.31 μM |
++
ERK2, Ki: 0.14 μM |
98% | ||||||||||||||||
| Ravoxertinib |
+++
ERK1, IC50: 1.1 nM |
++++
ERK2, IC50: 0.3 nM |
99%+ | ||||||||||||||||
| SCH772984 |
+++
ERK1, IC50: 4 nM |
++++
ERK2, IC50: 1 nM |
99%+ | ||||||||||||||||
| Temuterkib |
+++
ERK1, IC50: 5 nM |
+++
ERK2, IC50: 5 nM |
99%+ | ||||||||||||||||
| VX-11e |
+++
ERK2, Ki: <2 nM |
99%+ | |||||||||||||||||
| Ulixertinib |
++++
ERK2, IC50: <0.3 nM |
99%+ | |||||||||||||||||
| XMD17-109 |
++
ERK5, IC50: 162 nM |
99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | β-Elemene is a natural sesquiterpene found in various plants and imparts floral aromas to some plants. This compound has been reported to inhibit the proliferation of a wide range of tumors. |
| Concentration | Treated Time | Description | References | |
| NCI-H226 cells | 10 µg/ml | 24 hours | Β-Elemene significantly up-regulated C3orf21 expression | Front Oncol. 2021 May 7;11:571476 |
| MSTO-211H cells | 10 µg/ml | 24 hours | Β-Elemene significantly up-regulated C3orf21 expression | Front Oncol. 2021 May 7;11:571476 |
| U87MG cells | 10 μg/mL | 1 day | Cell viability was significantly decreased in a dose-dependent manner. | Am J Cancer Res. 2021 Feb 1;11(2):370-388 |
| SGC7901 human gastric cancer cells | 30 μg/mL | 18 hours | To evaluate the effect of β-elemene on the radiosensitivity of gastric cancer cells, results showed that β-elemene pretreatment decreased clonogenic survival | World J Gastroenterol. 2015 Sep 14;21(34):9945-56 |
| MKN45 human gastric cancer cells | 15 μg/mL | 18 hours | To evaluate the effect of β-elemene on the radiosensitivity of gastric cancer cells, results showed that β-elemene pretreatment decreased clonogenic survival | World J Gastroenterol. 2015 Sep 14;21(34):9945-56 |
| DBTRG-05MG cells | 10 μg/mL | 2 days | Induced senescence in glioma cells, with the percentage of SA-β-gal positive cells significantly increased to approximately 50%. | Am J Cancer Res. 2021 Feb 1;11(2):370-388 |
| C6 cells | 10 μg/mL | 2 days | Induced senescence in glioma cells, including reduction of cell proliferation, hypertrophic morphology, increase of SA-β-Gal activity, upregulation of senescence-associated genes such as p16, p53 and NF-κB, and down-regulation of Lamin B1. | Am J Cancer Res. 2021 Feb 1;11(2):370-388 |
| SPC-A-1 cells | 120 μg/mL | 24 hours | To evaluate the effect of β-Elemene on the expression of lysosomal biogenesis-related genes, results showed β-Elemene significantly upregulated mRNA expression of GLA, MCOLN1, and SLC26A11. | J Adv Res. 2024 Aug;62:257-272 |
| NCI-H460 cells | 120 μg/mL | 24 hours | To investigate the effect of β-Elemene on TFEB activation and lysosomal function, results showed β-Elemene significantly increased lysosomal acidification and TFEB nuclear translocation. | J Adv Res. 2024 Aug;62:257-272 |
| A549 cells | 120 μg/mL | 24 hours | To observe the effect of β-Elemene on TFEB activation and GPX4 lysosomal degradation, results showed β-Elemene significantly reduced TFEB phosphorylation, promoted its nuclear translocation, and increased GPX4 lysosomal degradation. | J Adv Res. 2024 Aug;62:257-272 |
| HCT116p53−/− cells | 40 μg/ml | 24 hours | Β-Elemene significantly inhibited the proliferation of HCT116p53−/− cells and reversed their resistance to 5-Fu. | Front Bioeng Biotechnol. 2020 May 8;8:378 |
| Human hepatoma HepG2 cells | 0.02, 0.04, 0.08 mg/mL | 24 hours | To detect the effect of β-elemene on microtubule polymerization, results showed that β-elemene reduced microtubule polymerization in a dose-dependent manner. | Chin J Cancer Res. 2013 Dec;25(6):770-6 |
| Human hepatoma HepG2 cells | 0.02, 0.04, 0.08 mg/mL | 24 hours | To detect the effect of β-elemene on α-tubulin mRNA expression, results showed that β-elemene down-regulated α-tubulin mRNA expression in a dose-dependent manner. | Chin J Cancer Res. 2013 Dec;25(6):770-6 |
| Human hepatoma HepG2 cells | 0.02, 0.04, 0.08 mg/mL | 24 hours | To detect the effect of β-elemene on HepG2 cell cycle, results showed that β-elemene induced cell cycle arrest at S phase in a dose-dependent manner. | Chin J Cancer Res. 2013 Dec;25(6):770-6 |
| BV-2 cells | 40 µM and 80 µM | 24 hours | Β-Elemene promoted the transformation of BV-2 cells from M1-like to M2-like phenotype, inhibited inflammatory factor release, thereby reducing neuronal apoptosis. | Chin Med. 2024 Jun 15;19(1):86 |
| NCI-H1650 cells | 50 μg/ml | 24 hours | To investigate the effect of β-elemene on the Warburg effect in NCI-H1650 cells and its mechanism. Results showed that β-elemene suppressed the Warburg effect by regulating the miR-301a-3p/AMPKα axis, as evidenced by decreased glucose and lactic acid levels and downregulation of metabolism-related enzymes (GLUT1, HK1, and LDHA). | Biosci Rep. 2020 Jun 26;40(6):BSR20194389 |
| CaSki cells | 0.18 mg/mL | 24 hours | Evaluate the inhibitory effect of β-Elemene on CaSki cells, showing nearly 50% inhibition at 0.18 mg/mL | Int J Pharm X. 2024 Aug 13;8:100276 |
| Hela cells | 0.09 mg/mL | 24 hours | Evaluate the inhibitory effect of β-Elemene on Hela cells, showing nearly 50% inhibition at 0.09 mg/mL | Int J Pharm X. 2024 Aug 13;8:100276 |
| RAW 264 cells | 10 μg/ml | 24 hours | To study the inhibitory effect of β-Elemene on LPS-induced inflammatory response, results showed that β-Elemene significantly reduced the production of inflammatory cytokines. | Commun Biol. 2022 May 31;5(1):519 |
| PP-CD11c+ DCs | 1, 2, 5, 10 μg/mL | 24 hours | To evaluate the effects of β-elemene on the expression of TGF-β1, RALDH2, integrin αvβ8, and IL-10 in PP DCs. Results showed that β-elemene significantly increased the expression of these molecules, indicating its role in promoting Tregs generation by modulating DCs function. | iScience. 2020 Nov 30;24(1):101883 |
| MLN-CD11c+ DCs | 1, 2, 5, 10 μg/mL | 24 hours | To evaluate the effects of β-elemene on the expression of TGF-β1, RALDH2, integrin αvβ8, and IL-10 in MLN DCs. Results showed that β-elemene significantly increased the expression of these molecules, indicating its role in promoting Tregs generation by modulating DCs function. | iScience. 2020 Nov 30;24(1):101883 |
| MAT SVCs | 1, 2, 5, 10 μg/mL | 24 hours | To evaluate the direct anti-inflammatory effects of β-elemene on SVCs from EAT and MAT of obese mice. Results showed that β-elemene had limited effects on LPS-induced inflammation in vitro, with significant effects only at high concentration (10 μg/mL) on CCL2 expression in MAT SVCs. | iScience. 2020 Nov 30;24(1):101883 |
| EAT SVCs | 1, 2, 5, 10 μg/mL | 24 hours | To evaluate the direct anti-inflammatory effects of β-elemene on SVCs from EAT and MAT of obese mice. Results showed that β-elemene had limited effects on LPS-induced inflammation in vitro, with significant effects only at high concentration (10 μg/mL) on IL-1β, TGF-β1, and IL-10 expression in EAT SVCs. | iScience. 2020 Nov 30;24(1):101883 |
| NRK49F cells | 5-20 µM | 24 hours | Β-elemene inhibited TGF-β-induced fibroblast activation and expression of fiber markers in a dose-dependent manner | Int J Mol Sci. 2022 May 16;23(10):5553 |
| NCI-H1650 cells | 3 μg/mL | 24 hours | To evaluate the effect of β-elemene on the survival and apoptosis of NCI-H1650 cells. Results showed that β-elemene significantly reduced cell viability and promoted apoptosis. | Am J Cancer Res. 2022 Apr 15;12(4):1535-1555 |
| A549 cells | 3 μg/mL | 24 hours | To evaluate the effect of β-elemene on the survival and apoptosis of A549 cells. Results showed that β-elemene significantly reduced cell viability and promoted apoptosis. | Am J Cancer Res. 2022 Apr 15;12(4):1535-1555 |
| NCI-H1975 cells | 10 µg/ml | 24 hours | Β-Elemene significantly up-regulated C3orf21 expression | Front Oncol. 2021 May 7;11:571476 |
| PC-9 cells | 10 µg/ml | 24 hours | Β-Elemene significantly up-regulated C3orf21 expression and inhibited cell proliferation, wound healing, and invasion | Front Oncol. 2021 May 7;11:571476 |
| A549 cells | 10 µg/ml | 24 hours | Β-Elemene significantly up-regulated C3orf21 expression and inhibited cell proliferation, wound healing, and invasion | Front Oncol. 2021 May 7;11:571476 |
| Human hepatoma HepG2 cells | 0.1, 0.08, 0.06, 0.04, 0.02, 0.01 mg/mL | 24, 48, 72 hours | To evaluate the inhibitory effect of β-elemene on HepG2 cell proliferation, results showed that β-elemene inhibited HepG2 cell proliferation in a time- and dose-dependent manner. | Chin J Cancer Res. 2013 Dec;25(6):770-6 |
| MCAS cells | 20-200 µg/ml | 24, 48, 72, and 96 hours | To evaluate the antiproliferative effect of β-elemene on MCAS cells, showing IC50 values between 60 and 78 µg/ml. | Int J Oncol. 2013 Sep;43(3):721-8 |
| A2780/CP70 cells | 20-200 µg/ml | 24, 48, 72, and 96 hours | To evaluate the antiproliferative effect of β-elemene on A2780/CP70 cells, showing IC50 values at 24, 48, 72, and 96 h were 80, 70, 68, and 65 µg/ml, respectively. | Int J Oncol. 2013 Sep;43(3):721-8 |
| A2780 cells | 20-200 µg/ml | 24, 48, 72, and 96 hours | To evaluate the antiproliferative effect of β-elemene on A2780 cells, showing IC50 values at 24, 48, 72, and 96 h were 65, 65, 65, and 60 µg/ml, respectively. | Int J Oncol. 2013 Sep;43(3):721-8 |
| H1299 cells | 2 mg/mL | 24, 48, and 72 hours | To evaluate the effects of β-Elemene on proliferation, apoptosis, and autophagy in NSCLC cells. Results showed that β-Elemene significantly inhibited NSCLC cell proliferation and induced autophagy and apoptosis. | J Pharm Anal. 2024 Sep;14(9):100961 |
| A549 cells | 2 mg/mL | 24, 48, and 72 hours | To evaluate the effects of β-Elemene on proliferation, apoptosis, and autophagy in NSCLC cells. Results showed that β-Elemene significantly inhibited NSCLC cell proliferation and induced autophagy and apoptosis. | J Pharm Anal. 2024 Sep;14(9):100961 |
| PC9 cells | 5-60 μg/ml | 24-72 hours | Β-Elemene inhibited PC9 cell growth in a dose- and time-dependent manner, with a maximal dose of 40 μg/ml observed at 48 hrs. | J Cell Mol Med. 2015 Mar;19(3):630-41 |
| A549 cells | 5-60 μg/ml | 24-72 hours | Β-Elemene inhibited A549 cell growth in a dose- and time-dependent manner, with a maximal dose of 40 μg/ml observed at 48 hrs. Additionally, β-Elemene significantly increased the proportion of cells at G0/G1 phase while reducing the proportion at S phase, indicating cell cycle arrest at G0/G1 phase. | J Cell Mol Med. 2015 Mar;19(3):630-41 |
| Primary human airway granulation fibroblasts (PHAGF) | 160 µg/mL | 48 hours | Inhibits PHAGF proliferation and induces G0/G1 cell cycle arrest and apoptosis by down-regulating the ILK/Akt pathway | Cell Mol Biol Lett. 2021 Jun 12;26(1):28 |
| THLE2 cells | 100 µg/mL | 48 hours | Β-Elemene showed no significant inhibition on the proliferation of normal hepatocytes THLE2. | Endocr Relat Cancer. 2019 Feb;26(2):187-199 |
| MHH-ES-1 cells | 47.86 µg/mL (IC50) | 48 hours | Β-Elemene significantly inhibited the proliferation of MHH-ES-1 cells in a dose-dependent manner. | Endocr Relat Cancer. 2019 Feb;26(2):187-199 |
| A673 cells | 38.02 µg/mL (IC50) | 48 hours | Β-Elemene significantly inhibited the proliferation of A673 cells in a dose-dependent manner. | Endocr Relat Cancer. 2019 Feb;26(2):187-199 |
| SU-DHL-10 cells | 60 μg/ml | 48 hours | To evaluate the effect of β-elemene on apoptosis of DLBCL cells, the results showed that β-elemene significantly up-regulated Bax expression and down-regulated Bcl-2 expression. | Biosci Rep. 2020 Feb 28;40(2):BSR20190804 |
| SU-DHL-8 cells | 60 μg/ml | 48 hours | To evaluate the effect of β-elemene on apoptosis of DLBCL cells, the results showed that β-elemene significantly up-regulated Bax expression and down-regulated Bcl-2 expression. | Biosci Rep. 2020 Feb 28;40(2):BSR20190804 |
| MHCCLM3 | 60 μg/mL | 48 hours | Β-Elemene combined with oxaliplatin significantly enhanced the anti-proliferative effect of oxaliplatin by upregulating CTR1 expression, increasing intracellular platinum accumulation. | Sci Rep. 2016 Feb 12;6:21010 |
| Huh7 | 60 μg/mL | 48 hours | Β-Elemene combined with oxaliplatin significantly enhanced the anti-proliferative effect of oxaliplatin by upregulating CTR1 expression, increasing intracellular platinum accumulation. | Sci Rep. 2016 Feb 12;6:21010 |
| Hep3B | 60 μg/mL | 48 hours | Β-Elemene combined with oxaliplatin significantly enhanced the anti-proliferative effect of oxaliplatin by upregulating CTR1 expression, increasing intracellular platinum accumulation. | Sci Rep. 2016 Feb 12;6:21010 |
| MHCC97H | 60 μg/mL | 48 hours | Β-Elemene enhanced the anti-proliferative effect of oxaliplatin by upregulating the expression of copper transporter 1 (CTR1), increasing intracellular platinum accumulation and platinum-DNA adduct formation, thereby enhancing oxaliplatin-induced apoptosis. | Sci Rep. 2016 Feb 12;6:21010 |
| Tca-8113-CDDP cells | 40 μg/ml | 48 hours | To explore the sensitizing effect of β-Ele on cisplatin-resistant OSCC cells. The results showed that β-Ele significantly enhanced the chemosensitivity to cisplatin in Tca-8113-CDDP cells. | Cancer Cell Int. 2022 Jul 31;22(1):244 |
| Tca-8113 cells | 0, 20, 40, 60, 80, 100 μg/ml | 48 hours | To evaluate the anti-proliferative effect of β-Ele on OSCC cells. The results showed that β-Ele suppressed the growth and proliferation of Tca-8113 and Tca-8113-CDDP cells in dose-dependent manners. | Cancer Cell Int. 2022 Jul 31;22(1):244 |
| Primary human airway granulation fibroblasts | 40, 80, 120, 160 μg/ml | 48 hours | Β-Elemene had a dose–responsive inhibitive effect on the proliferation of human airway granulation fibroblasts and didn’t affect normal human airway fibroblasts. | Biosci Rep. 2018 Apr 13;38(2):BSR20171386 |
| AGS/IR cells | 100 mg/L | 48 hours | To evaluate the effect of β-Elemene on radiosensitivity, results showed that β-Elemene significantly inhibited cell growth and enhanced ferroptosis. | Front Pharmacol. 2024 Oct 17;15:1469180 |
| MKN-45/IR cells | 100 mg/L | 48 hours | To evaluate the effect of β-Elemene on radiosensitivity, results showed that β-Elemene significantly inhibited cell growth and enhanced ferroptosis. | Front Pharmacol. 2024 Oct 17;15:1469180 |
| MCF-7 cells | 5, 10, 20 and 40 µM | 48 hours | Β-Elemene at concentrations below 40 μmol/L did not inhibit the viability of MCF-7 cells but significantly inhibited cell migration and invasion. | J Cell Mol Med. 2019 Oct;23(10):6846-6858 |
| MDA-MB-231 cells | 5, 10, 20 and 40 µM | 48 hours | Β-Elemene at concentrations below 40 μmol/L did not inhibit the viability of MDA-MB-231 cells but significantly inhibited cell migration and invasion. | J Cell Mol Med. 2019 Oct;23(10):6846-6858 |
| Pancreatic cancer peritoneum effusion cells | 0, 0.5, 1, 2, 4, 8 and 16 µM | 72 hours | Β-Elemene suppressed the proliferation of pancreatic cancer peritoneum effusion cells in a dose-dependent manner, with IC50 values of 15.80±0.63 and 14.86±0.69 µM. | Oncol Rep. 2019 Dec;42(6):2561-2571 |
| BxPC3 cells | 0, 0.5, 1, 2, 4, 8 and 16 µM | 72 hours | Β-Elemene suppressed the proliferation of BxPC3 cells in a dose-dependent manner, with an IC50 value of 17.36±1.25 µM. | Oncol Rep. 2019 Dec;42(6):2561-2571 |
| PANC-1 cells | 0, 0.5, 1, 2, 4, 8 and 16 µM | 72 hours | Β-Elemene suppressed the proliferation of PANC-1 cells in a dose-dependent manner, with an IC50 value of 6.94±0.86 µM. | Oncol Rep. 2019 Dec;42(6):2561-2571 |
| Administration | Dosage | Frequency | Description | References | ||
| Nude mice | Subcutaneous tumor model | Gavage | 0.2 mL per administration | 36 days | To evaluate the inhibitory effect of β-Elemene combined with radiotherapy on tumor growth, results showed that the combination therapy significantly inhibited tumor growth. | Front Pharmacol. 2024 Oct 17;15:1469180 |
| C57BL/6J neonatal mice | Oxygen-induced retinopathy (OIR) model | Intravitreal injection | 0.25 mg/ml (1 µl) | Single injection, lasting 5 days (P12-P17) | Β-Elemene reduced retinal neovascularization by upregulating miR-27a expression, leading to decreased VEGF expression. | Mol Med Rep. 2019 Mar;19(3):2307-2316 |
| BALB/c nude mice | HCT116p53−/− xenograft model | Intraperitoneal injection | 100 mg/kg/d | Once daily for 24 days | Β-Elemene significantly inhibited the growth of HCT116p53?/? xenograft tumors and enhanced the anti-tumor effect of 5-Fu. | Front Bioeng Biotechnol. 2020 May 8;8:378 |
| BALB/C nude mice | Glioma xenograft model | Intraperitoneal injection | 100 mg/kg/d | Once daily for 23 days | Β-Elemene treatment induced senescence in glioma cells through inactivation of YAP-CDK6 signaling pathway, which inhibited glioma growth. | Am J Cancer Res. 2021 Feb 1;11(2):370-388 |
| NOD/SCID mice | Orthotopic non-small cell lung cancer model | Tail vein injection | 120 mg/kg | Once daily for 21 days | To evaluate the antitumor effect of β-Elemene in TFEB knockout mice, results showed TFEB knockout attenuated the inhibitory effect of β-Elemene on tumor growth. | J Adv Res. 2024 Aug;62:257-272 |
| New Zealand white rabbits | Rabbit model of tracheal stenosis | Local endotracheal injection | 160 µg/mL | Once a week for one week | Inhibits airway granulation tissue hyperplasia and alleviates tracheal stenosis | Cell Mol Biol Lett. 2021 Jun 12;26(1):28 |
| C57BL/6J mice | MCAO model and photothrombotic stroke model | Intraperitoneal injection | 25 mg/kg, 50 mg/kg, 100 mg/kg | 1 hour before ischemia and 5 hours after reperfusion | Β-Elemene attenuated neurological deficit, reduced the infarction volume and neuroinflammation, thus improving ischemic stroke injury. | Chin Med. 2024 Jun 15;19(1):86 |
| C57BL/6 mice | Unilateral ureteral obstruction (UUO) model | Intraperitoneal injection | 40 mg/kg/d | Once daily for 7 days | Β-Elemene attenuated renal fibrosis in UUO mice by inhibition of STAT3 and Smad3 signaling | Int J Mol Sci. 2022 May 16;23(10):5553 |
| BALB/C mice | DLBCL xenograft model | Intraperitoneal injection | 45 mg/kg | Once daily for 28 days | To evaluate the inhibitory effect of β-Elemene on the growth of DLBCL xenograft, the results showed that β-Elemene significantly suppressed tumor growth, down-regulated HULC expression, up-regulated Bax expression, and down-regulated Bcl-2 expression. | Biosci Rep. 2020 Feb 28;40(2):BSR20190804 |
| BALB/c nude mice | OSCC xenograft model | Intraperitoneal injection | 45 mg/kg β-Ele and/or 4 mg/kg cisplatin | Every three days for 27 days | To evaluate the inhibitory effect of β-Ele and cisplatin combination therapy on the growth of OSCC xenograft tumors. The results showed that β-Ele and cisplatin synergistically suppressed tumor growth and induced apoptosis, possibly by inhibiting the JAK/STAT3 signaling pathway. | Cancer Cell Int. 2022 Jul 31;22(1):244 |
| Nude mice | Orthotopic transplantation HCC model | Intraperitoneal injection | 45 mg/kg β-elemene and 5 mg/kg oxaliplatin | Twice a week for 7 weeks | Β-Elemene combined with oxaliplatin significantly inhibited HCC tumor growth in nude mice by upregulating CTR1 expression, increasing intracellular oxaliplatin accumulation, thereby enhancing the anti-tumor effect of oxaliplatin. | Sci Rep. 2016 Feb 12;6:21010 |
| BALB/c-nu mice | A549 cell subcutaneous xenograft model | Intraperitoneal injection | 5 mg/kg | Once daily for 7 days | To evaluate the inhibitory effect of β-Elemene on the growth of A549 cell subcutaneous xenografts. Results showed that β-Elemene significantly suppressed tumor growth. | Am J Cancer Res. 2022 Apr 15;12(4):1535-1555 |
| BALB/c nude mice | NSCLC xenograft model | Oral gavage | 50 mg/kg | Every other day for 2 weeks | Β-Elemene suppresses tumor growth by downregulating ALDH3A1 expression, reducing glucose uptake, and inhibiting glycolysis. | Cell Death Dis. 2023 Sep 20;14(9):617 |
| BALB/c nude mice | Orthotopic breast cancer xenograft model | Intraperitoneal injection | 50 mg/kg | Once daily for 21 days | Β-Elemene significantly reduced metastatic foci of breast cancer in the lung and liver. | J Cell Mol Med. 2019 Oct;23(10):6846-6858 |
| Nude mice | HCC827/GR xenograft model | Intravenous injection | 50 mg/kg | Daily for an unspecified duration | To evaluate the antitumor efficacy of β-Elemene in combination with gefitinib, results showed that the combination treatment significantly suppressed tumor growth. | Pharmaceuticals (Basel). 2024 May 14;17(5):626 |
| BALB/c nude mice | A673 xenograft model | Peritumoral injection | 50 mg/kg and 100 mg/kg | Once daily for 17 days | Β-Elemene significantly inhibited the growth of A673 xenografts, with a 72% inhibition rate in the high-dose group. | Endocr Relat Cancer. 2019 Feb;26(2):187-199 |
| C57BL/6 male mice | High-fat diet-induced obese mouse model | Gavage | 7.5 mg/kg/d | Once daily for 3 weeks | Β-Elemene suppressed experimental obesity-induced chronic inflammation by adjusting the intestinal immune system of obese mice and partially reversed HFD-induced changes in the composition and contents of mouse gut bacteria. | Biomedicines. 2021 Jun 22;9(7):704 |
| Mice | High-fat diet-induced obesity model | Gavage | 7.5 mg/kg/d | Once daily for 3 weeks | To study the regulatory effect of β-Elemene on inflammatory response in obese mice, results showed that β-Elemene significantly reduced blood glucose levels and the expression of inflammatory cytokines. | Commun Biol. 2022 May 31;5(1):519 |
| C57BL/6 male mice | High-fat diet-induced obese mouse model | Oral gavage | 7.5 mg/kg/d | Once daily for 3 weeks | To evaluate the effects of β-Elemene on adipose tissue inflammation and Tregs in obese mice. Results showed that oral administration of β-Elemene significantly downregulated the expression of inflammatory cytokines (TNF-α, IL-1β, IL-6) in adipose tissue and increased the proportion of Foxp3+CD4+ T cells, indicating its role in alleviating obesity-induced chronic inflammation by modulating DCs function in the intestinal immune system. | iScience. 2020 Nov 30;24(1):101883 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.89mL 0.98mL 0.49mL |
24.47mL 4.89mL 2.45mL |
48.94mL 9.79mL 4.89mL |
|
| CAS号 | 515-13-9 |
| 分子式 | C15H24 |
| 分子量 | 204.35 |
| SMILES Code | C=C[C@@]1(C)[C@H](C(C)=C)C[C@H](C(C)=C)CC1 |
| MDL No. | MFCD00468041 |
| 别名 | B-榄香烯 ;Levo-β-elemene; (-)-β-Elemene |
| 运输 | 蓝冰 |
| InChI Key | OPFTUNCRGUEPRZ-QLFBSQMISA-N |
| Pubchem ID | 6918391 |
| 存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 |
| 溶解方案 |
DMSO: 50 mg/mL(244.68 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 无水乙醇: 50 mg/mL(244.68 mM),配合低频超声助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1